Donate

No summary is available yet.

Version:

WHEREAS, Cystic fibrosis is the second most common chronic, progressive, and life-threatening genetic disease in the United States, and one for which there is no known cure; and

WHEREAS, Approximately 30,000 children and adults in the United States have cystic fibrosis and more than 1,000 new cases are diagnosed each year; and

WHEREAS, During the 1950s, few children with cystic fibrosis lived long enough to attend elementary school; and

WHEREAS, Due to progress in understanding and treating the disease, many people living with cystic fibrosis can now expect to live into their 40s and beyond; and

WHEREAS, One of every 3,500 babies born in the United States is born with cystic fibrosis; and

WHEREAS, The federal Centers for Disease Control and Prevention (CDC) estimates that more than 12 million Americans are unknowing, symptomless carriers of the cystic fibrosis gene and have high odds of passing the gene to their children; and

WHEREAS, The CDC recommends that all states consider screening newborns for cystic fibrosis; and

WHEREAS, The Cystic Fibrosis Foundation urges all states to implement newborn screening for cystic fibrosis to facilitate early diagnosis and treatment that improves health and longevity; and

WHEREAS, Prompt, aggressive treatment of the symptoms of cystic fibrosis can extend the lives of people who have the disease; and

WHEREAS, Recent advances in cystic fibrosis research have produced promising leads in gene, protein, and drug therapies beneficial to people who have the disease; and

WHEREAS, Innovative research is progressing faster, and is being conducted more aggressively, than ever before, due, in part, to the Cystic Fibrosis Foundations establishment of a model clinical trials network; and

WHEREAS, Although the Cystic Fibrosis Foundation continues to fund a research pipeline for more than two dozen potential therapies and funds a nationwide network of care centers that extend the length and quality of life for people with cystic fibrosis, lives continue to be lost to this disease every day; and

WHEREAS, Cystic Fibrosis Research Inc. is a California-based organization that funds research, provides personal support, and spreads awareness of cystic fibrosis; and

WHEREAS, Education of the public about cystic fibrosis, including the symptoms of the disease, increases knowledge and understanding of cystic fibrosis and promotes early diagnosis; and

WHEREAS, The Cystic Fibrosis Foundation will conduct activities to honor National Cystic Fibrosis Awareness Month during May 2016; now, therefore, be it

Resolved by the Senate of the State of California, That the Senate proclaims the month of May 2016 as Cystic Fibrosis Awareness Month; and be it further

Resolved, That the Senate honors the goals and ideals of Cystic Fibrosis Awareness Month so as to promote further public awareness and understanding of cystic fibrosis; and be it further

Resolved, That the Senate encourages early diagnosis and access to quality care for people with cystic fibrosis to improve the quality of their lives, advocates for increased support for people who have cystic fibrosis and their families, and supports research to find a cure for cystic fibrosis; and be it further

Resolved, That the Secretary of the Senate transmit copies of this resolution to the author for appropriate distribution.